Literature DB >> 34498172

Incidence, prevalence and disability associated with neurological disorders in Italy between 1990 and 2019: an analysis based on the Global Burden of Disease Study 2019.

Alberto Raggi1, Lorenzo Monasta2, Ettore Beghi3, Valeria Caso4, Giulio Castelpietra5, Stefania Mondello6, Giorgia Giussani3, Giancarlo Logroscino7, Francesca Giulia Magnani8, Marco Piccininni9, Elisabetta Pupillo3, Stefano Ricci10, Luca Ronfani2, Paola Santalucia11, Davide Sattin8, Silvia Schiavolin8, Claudia Toppo8, Eugenio Traini2,12, Jaimie Steinmetz13, Emma Nichols13, Rui Ma13, Theo Vos13, Valery Feigin14, Matilde Leonardi8.   

Abstract

BACKGROUND: Neurological conditions are highly prevalent and disabling, in particular in the elderly. The Italian population has witnessed sharp ageing and we can thus expect a rising trend in the incidence, prevalence and disability of these conditions.
METHODS: We relied on the Global Burden of Disease 2019 study to extract Italian data on incidence, prevalence and years lived with a disability (YLDs) referred to a broad set of neurological disorders including, brain and nervous system cancers, stroke, encephalitis, meningitis, tetanus, traumatic brain injury, and spinal cord injury. We assessed changes between 1990 and 2019 in counts and age-standardized rates.
RESULTS: The most prevalent conditions were tension-type headache, migraine, and dementias, whereas the most disabling were migraine, dementias and traumatic brain injury. YLDs associated with neurological conditions increased by 22.5%, but decreased by 2.3% in age-standardized rates. The overall increase in prevalence and YLDs counts was stronger for non-communicable diseases with onset in old age compared to young to adult-age onset ones. The same trends were in the opposite direction when age-standardized rates were taken into account.
CONCLUSIONS: The increase in YLDs associated with neurological conditions is mostly due to population ageing and growth: nevertheless, lived disability and, as a consequence, impact on health systems has increased. Actions are needed to improve outcome and mitigate disability associated with neurological conditions, spanning among diagnosis, treatment, care pathways and workplace interventions.
© 2021. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Dementia; Disability; Migraine; Motor neuron disease; Multiple sclerosis; Stroke

Mesh:

Year:  2021        PMID: 34498172     DOI: 10.1007/s00415-021-10774-5

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   6.682


  41 in total

1.  Aging in Italy: The Need for New Welfare Strategies in an Old Country.

Authors:  Paolo Mazzola; Stefania Maria Lorenza Rimoldi; Paolo Rossi; Marianna Noale; Federico Rea; Carla Facchini; Stefania Maggi; Giovanni Corrao; Giorgio Annoni
Journal:  Gerontologist       Date:  2015-11-09

2.  Burden of brain disorders in Europe in 2017 and comparison with other non-communicable disease groups.

Authors:  Alberto Raggi; Matilde Leonardi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2019-06-17       Impact factor: 10.154

3.  Disability weights for the Global Burden of Disease 2013 study.

Authors:  Joshua A Salomon; Juanita A Haagsma; Adrian Davis; Charline Maertens de Noordhout; Suzanne Polinder; Arie H Havelaar; Alessandro Cassini; Brecht Devleesschauwer; Mirjam Kretzschmar; Niko Speybroeck; Christopher J L Murray; Theo Vos
Journal:  Lancet Glob Health       Date:  2015-11       Impact factor: 26.763

Review 4.  Behavioral Approaches for Primary Headaches: Recent Advances.

Authors:  Alberto Raggi; Eleonora Grignani; Matilde Leonardi; Frank Andrasik; Emanuela Sansone; Licia Grazzi; Domenico D'Amico
Journal:  Headache       Date:  2018-05-26       Impact factor: 5.887

Review 5.  Usefulness of nutraceuticals in migraine prophylaxis.

Authors:  Florindo D'Onofrio; Simona Raimo; Daniele Spitaleri; Gerardo Casucci; Gennaro Bussone
Journal:  Neurol Sci       Date:  2017-05       Impact factor: 3.307

Review 6.  Current Prophylactic Medications for Migraine and Their Potential Mechanisms of Action.

Authors:  Till Sprenger; M Viana; C Tassorelli
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

Review 7.  An Update on Non-Pharmacological Neuromodulation for the Acute and Preventive Treatment of Migraine.

Authors:  Francesca Puledda; Peter J Goadsby
Journal:  Headache       Date:  2017-03-13       Impact factor: 5.887

Review 8.  The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies.

Authors:  Michael J Marmura; Stephen D Silberstein; Todd J Schwedt
Journal:  Headache       Date:  2015-01       Impact factor: 5.887

9.  MAB-MIG: registry of the spanish neurological society of erenumab for migraine prevention.

Authors:  Robert Belvís; Pablo Irimia; Patricia Pozo-Rosich; Carmen González-Oria; Antonio Cano; Javier Viguera; Belén Sánchez; Francisco Molina; Isabel Beltrán; Agustín Oterino; Elisa Cuadrado; Angel Gómez-Camello; Miguel Alberte-Woodward; Carmen Jurado; Teresa Oms; David Ezpeleta; Javier Díaz de Terán; Noemí Morollón; Germán Latorre; Marta Torres-Ferrús; Alicia Alpuente; Raquel Lamas; Carlos Toledano; Rogelio Leira; Sonia Santos; Margarita Sánchez Del Río
Journal:  J Headache Pain       Date:  2021-07-17       Impact factor: 7.277

View more
  3 in total

1.  Addressing the cost of chronic and episodic migraine and its main drivers: a short-term longitudinal analysis from a third-level Italian center.

Authors:  Alberto Raggi; Licia Grazzi; Erika Guastafierro; Alessia Marcassoli; Marco Passavanti; Danilo Antonio Montisano; Domenico D'Amico
Journal:  Neurol Sci       Date:  2022-05-27       Impact factor: 3.830

2.  Managing of Migraine in the Workplaces: Knowledge, Attitudes and Practices of Italian Occupational Physicians.

Authors:  Matteo Riccò; Pietro Ferraro; Vincenzo Camisa; Pasquale Di Palma; Giuseppa Minutolo; Silvia Ranzieri; Salvatore Zaffina; Antonio Baldassarre; Vincenzo Restivo
Journal:  Medicina (Kaunas)       Date:  2022-05-22       Impact factor: 2.948

3.  Xiongshao Zhitong Recipe Attenuates Nitroglycerin-Induced Migraine-Like Behaviors via the Inhibition of Inflammation Mediated by Nitric Oxide Synthase.

Authors:  Song Yang; Cong Chen; Xiaoyao Liu; Qianjun Kang; Quantao Ma; Pin Li; Yujie Hu; Jialin Li; Jian Gao; Ting Wang; Weiling Wang
Journal:  Front Pharmacol       Date:  2022-07-19       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.